Top Workplace Converted to Santa's Workshop on Giving Tuesday to Spread 'Big Love' This Holiday Season

December 2, 2025 1:00 PM

US Med-Equip's workshop ordinarily contains life-saving equipment for hospitals, but this Giving Tuesday Santa's elves at the "Top Workplace" also spread holiday cheer to children and families supported by B.I.G. Love Cancer Care.US Med-Equip (USME) elves are collecting toys, blankets, art supplies, cozy pajamas and more for kids spending their holidays in the hospital."Every day, our teams move mountains to help hospitals care for patients when...

Read more

Catalyzing Change in Specialty Care: DaVita Shares Vision for Technology Transformation

December 2, 2025 10:35 AM

Approximately 129 million Americans are living with at least one chronic condition, and fragmentation of care creates a significant hurdle as these individuals often find themselves navigating a complex web of health care services."When you have a chronic condition, you end up engaging with your specialist significantly more - over three times as often - than you do with your primary care physician," Joel Haugen, chief product officer for...

Read more

Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option

December 2, 2025 10:00 AM

Trial Library, an AI-enabled platform expanding access to clinical trials as a care option, announced a $10 million Series A funding round co-led by SemperVirens Venture Capital and Next Ventures, with participation from Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest, Overwater Ventures and others. This investment, which brings total funding to date of $15 million, accelerates Trial Library's mission to make clinical...

Read more

John H. Weston Jr. Featured in New Industry Spotlight Highlighting Leadership in Developmental Disability Support

December 2, 2025 10:00 AM

Capitol City Residential Health Care CEO John H. Weston Jr. is the focus of a newly released feature article exploring his career, leadership philosophy, and long-standing commitment to supporting individuals with intellectual and developmental disabilities. Drawing from the interview, Weston is using the opportunity to call for greater public awareness, stronger community partnerships, and increased support for individuals who face both...

Read more

Tobinworld Calls for Greater Support for Children with Dual Diagnoses

December 2, 2025 9:55 AM

Tobinworld Mental Health, a long-standing non-profit dedicated to helping children and teens with developmental disabilities and mental health conditions, is calling for increased awareness and community involvement to support children with dual diagnoses. These are young people who live with both a developmental condition, such as autism, and a mental health disorder like anxiety, depression, or behavioral dysregulation."Many families struggle...

Read more

Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection

December 2, 2025 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the company is expanding its development efforts into a new generation of consumer-grade AI pre-health screening mobile applications designed to help identify early warning signs of serious health conditions and encourage timely medical intervention. This initiative builds upon MDCE's previously announced breakthrough in early melanoma detection. The company is now leveraging...

Read more

StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function

December 2, 2025 9:15 AM

StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, today announced the signing of a service agreement with the St. Boniface Hospital Albrechtsen Research Centre, affiliated with the University of Manitoba, and Principal Investigator, Professor Paul Fernyhough. This collaboration will explore the effects of StimCell's proprietary...

Read more

Lumina360 Platform to Streamline Complex Care for Skilled Nursing

December 2, 2025 9:00 AM

Lumina Care announced the launch of a new care delivery analysis platform, called Lumina360, that helps improve care continuity and quality throughout the patient journey. Lumina360 provides real-time vitals, statistics, information, and analysis that integrates with electronic health records (EHR) to create a clear picture of an individual patient's health and provides facility-level oversight, improving treatment outcomes and compliance.The...

Read more

Who Does the Best Tummy Tuck in Sarasota?

December 2, 2025 9:00 AM

For patients in Southwest Florida comparing tummy tuck options, one name comes up repeatedly in search results, professional directories, and third-party press coverage: Dr. Alberico J. Sessa, founder of Sarasota Surgical Arts and a cosmetic surgeon whose practice has become closely associated with abdominoplasty in the Sarasota area.A Sarasota Surgeon Whose Practice Centers on Tummy TuckOn the dedicated tummy tuck in Sarasota page of Sarasota...

Read more

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study

December 2, 2025 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar), today announced that its Italian subsidiary, Napo Therapeutics S.p.A., has submitted a request to the European Medicines Agency (EMA) to have the EMA's Committee for Veterinary Medicinal Products (CVMP) provide scientific advice regarding the company's plan to pursue approval of Canalevia (crofelemer delayed-release tablets) in the European Union for treatment of general diarrhea in dogs based on data...

Read more

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

December 2, 2025 9:00 AM

Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, is pleased to announce that on November 3, 2025, it submitted its Pre-IND meeting request and briefing package to the U.S. Food and Drug Administration (FDA). The submission concerns the Company's lead product candidate, a fast-acting, high-dose sublingual aspirin formulation for the treatment of...

Read more

Strive Pharmacy Breaks Ground on New 350,000 Sq. Ft. Arizona Headquarters and Compounding Facility, Strengthening Its National Leadership in Patient-Focused Innovation

December 2, 2025 9:00 AM

Strive Pharmacy, a national leader in patient-centered pharmaceutical compounding, officially broke ground today on its new 350,000-square-foot headquarters and advanced compounding facility in Mesa, Arizona. The milestone marks a significant step in Strive's long-term growth plan and deepens its commitment to the state where the company was founded.More than just an expansion of physical space, the new Arizona headquarters represents Strive's...

Read more

New US Hospital Cyber Resilience 2026 Report Delivers AI-Ready Playbook for Vendor and Cloud Incidents

December 2, 2025 8:45 AM

Black Book Market Research today announced the release of US Hospital Cyber Resilience 2026 - Volume 2: Identity, Insurance, and Incident Readiness, a free industry report that gives hospital and health system leaders a concrete playbook for managing cyber incidents originating in vendors, clouds, and AI platforms. The report is fully vendor-agnostic and advisory-firm neutral, does not recommend any specific providers, and is intended as a...

Read more

Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures

December 2, 2025 8:30 AM

Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture to establish distribution of Stemtech Products in China with Lightway Ventures. Stemtech Asia (Hong Kong) is being established, subject to final funding and regulatory approvals, and will be under the corporate structure of Stemtech Corporation, a Nevada USA holding company (OTCQB: "STEK").The China...

Read more

Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045

December 2, 2025 8:00 AM

Dogwood Therapeutics, Inc. (Nasdaq:DWTX) (the "Company"), a development-stage biotechnology company developing new medicines to treat pain and neuropathy, today announced it has filed for new intellectual property protection for synthetic Halneuron®. If granted, the IP's exclusivity period will extend to 2045, before additional patent term restoration extensions."We plan to use synthetically manufactured Halneuron® in both Phase 3 development...

Read more

Doctor Becomes First in Illinois to Perform Revolutionary, Minimally Invasive Bladder Control Procedure

December 2, 2025 8:00 AM

Dr. Sarah Martin, a women's urology specialist at Duly Health and Care's Chicagoland medical group, DuPage Medical Group, Ltd., this month became the first physician in Illinois to perform a cutting-edge, minimally invasive bladder control procedure using the Altaviva™ implant.Millions of women, including many in the Chicagoland area, now have access to a breakthrough treatment that has the potential to dramatically improve their quality of...

Read more

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

December 2, 2025 8:00 AM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics designed to minimize abuse and overdose risk, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a new patent covering Ensysce's MPAR® (Multi-Pill Abuse Resistance) technology. The patent, titled "Compositions Comprising...

Read more

Avel eCare Welcomes Pat Gundersen as New Chief Revenue Officer

December 2, 2025 7:12 AM

Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of leadership experience in healthcare, healthcare technology, and go-to-market strategy.Gundersen is a seasoned C-Suite leader known for building high-performing teams, strengthening client relationships, and accelerating growth for healthcare technology and service organizations. His background includes guiding...

Read more

CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show

December 2, 2025 7:00 AM

CBD Life Sciences Inc. (OTCID:CBDL) is gaining powerful investor momentum this week following a spotlight interview with CEO Lisa Nelson on The Morning Show. Nelson discussed CBDL's rapid expansion, new retail partnerships, rising demand for its flagship therapeutic products, and the company's long-term vision as it positions itself inside one of the fastest-growing wellness markets in the world. This high-visibility interview arrives during a...

Read more

GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases

December 2, 2025 12:00 AM

GEN Pharmaceuticals (GENIL.IS), Türkiye's leading specialty pharmaceutical company, has announced new positive results from its Phase 1 clinical trial evaluating the safety, tolerability, and pharmacokinetics (PK) of first-in-class, novel orally administered mitochondria-directed drug candidate SUL-238 in healthy elderly volunteers. The findings were presented at the 18th Clinical Trials on Alzheimer's Disease (CTAD) in San Diego, CA (United...

Read more